报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2025-03-31 | 76.68% | -4.81% | -3.53% | 13/129 | 51.32% | 佰仁医疗 | 85.72% | 行业排名> |
2024-12-31 | 79.49% | -2.18% | -1.12% | 7/129 | 52.31% | 佰仁医疗 | 88.34% | 行业排名> |
2024-09-30 | 80.39% | -1.62% | -0.82% | 6/129 | 53.43% | 佰仁医疗 | 88.56% | 行业排名> |
2024-06-30 | 81.05% | -0.49% | 0.62% | 5/129 | 53.65% | 佰仁医疗 | 89.27% | 行业排名> |
2024-03-31 | 80.56% | 0.17% | -0.86% | 8/129 | 53.43% | 佰仁医疗 | 89.28% | 行业排名> |
2023-12-31 | 81.26% | 24% | -0.56% | 6/129 | 53.5% | 正海生物 | 89.9% | 行业排名> |
2023-09-30 | 81.72% | 17.62% | 0.32% | 5/129 | 54.06% | 正海生物 | 90.39% | 行业排名> |
2023-06-30 | 81.46% | 19.7% | 1.28% | 7/129 | 53.61% | 正海生物 | 90.3% | 行业排名> |
2023-03-31 | 80.42% | 16.32% | 22.73% | 9/129 | 53.66% | 正海生物 | 89.78% | 行业排名> |
2022-12-31 | 65.53% | -12.19% | -5.68% | 40/129 | 54.04% | 三友医疗 | 90.18% | 行业排名> |
2022-09-30 | 69.48% | 2% | 2.09% | 30/129 | 55.13% | 三友医疗 | 90.14% | 行业排名> |
2022-06-30 | 68.05% | -11.19% | -1.58% | 34/129 | 54.78% | 三友医疗 | 90.29% | 行业排名> |
2022-03-31 | 69.14% | 2% | -7.35% | 33/129 | 56.28% | 三友医疗 | 90.73% | 行业排名> |
2021-12-31 | 74.62% | -1.65% | -2.61% | 22/129 | 57.38% | 三友医疗 | 90.5% | 行业排名> |
2021-06-30 | 76.63% | 2% | 0.99% | 18/129 | 58.42% | 三友医疗 | 90.29% | 行业排名> |
2020-12-31 | 75.87% | -14.63% | -14.63% | 27/129 | 59.67% | 正海生物 | 90.78% | 行业排名> |
2019-12-31 | 88.87% | 0.78% | 0.78% | 5/129 | 56.37% | 正海生物 | 91.59% | 行业排名> |
2018-12-31 | 88.18% | 2% | 2% | 5/129 | 55.53% | 正海生物 | 92.23% | 行业排名> |